L01XG Proteasome inhibitors, antineoplastic agent
ATC group of level 4 – chemical subgroup · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 43 medicines in this group and its subgroups.
- 22 prescription only (POM)
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
-
L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XG01 bortezomib 33 medicines
- L01XG02 carfilzomib 4 medicines
- L01XG03 ixazomib 6 medicines
-
L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Active substances in the group
- Bortezomib 33 medicines
- Carfilzomib 4 medicines
- Ixazomib 6 medicines
Medicines in the group and its subgroups
Other groups of the same level
- L01XA Platinum compounds, antineoplastic drugs 11 medicines
- L01XB Methylhydrazines, antineoplastics 1 medicine
- L01XC Monoclonal antibodies, antineoplastic 73 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01XF Retinoids for cancer treatment 2 medicines
- L01XH Histone deacetylase (HDAC) inhibitors 3 medicines
- L01XJ Hedgehog pathway inhibitors 4 medicines
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01XX Other antineoplastic agents 59 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
Other names of the ATC group
- German: L01XG Proteasom-Inhibitoren
- German: L01XG Proteasom-Inhibitoren
- Italian: L01XG Ibibitori dei proteasomi
- Turkish: L01XG Proteazom inhibitörleri, antineoplastik ajan
- Czech: L01XG Inhibitory proteazomu
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XG
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
